Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May;15(3):420-422.
doi: 10.1111/irv.12834. Epub 2021 Jan 4.

Public perception and performance of different sampling approaches for the diagnosis of COVID-19

Ngai Yung Tsang  1 , Hau Chi So  1 , Hiu Fai Ho  2 , Gabriel M Leung  1 , Dennis K M Ip  1
Affiliations

Public perception and performance of different sampling approaches for the diagnosis of COVID-19

Ngai Yung Tsang et al. Influenza Other Respir Viruses. 2021 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

All authors declare that there are no conflicts of interests.

Figures

FIGURE 1
FIGURE 1
Public preference on different sampling approaches for diagnosis of community COVID‐19 infection
See this image and copyright information in PMC

References

    1. Mohammadi A, Esmaeilzadeh E, Li Y, Bosch RJ, Li JZ. SARS‐CoV‐2 detection in different respiratory sites: A systematic review and meta‐analysis. EBioMedicine. 2020;59:102903. 10.1016/j.ebiom.2020.102903 - DOI - PMC - PubMed
    1. Lai CKC, Chen Z, Lui G, et al. Prospective Study Comparing Deep Throat Saliva With Other Respiratory Tract Specimens in the Diagnosis of Novel Coronavirus Disease 2019. The Journal of Infectious Diseases. 2020;222(10):1612–1619. 10.1093/infdis/jiaa487 - DOI - PMC - PubMed
    1. Hanson KE, Caliendo AM, Arias CA, et al. Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019 (COVID‐19): Serologic Testing. Clinical Infectious Diseases. 2020. 10.1093/cid/ciaa1343 - DOI - PMC - PubMed
    1. Pasomsub E, Watcharananan SP, Boonyawat K, et al. Saliva sample as a non‐invasive specimen for the diagnosis of coronavirus disease 2019: a cross‐sectional study. Clinical Microbiology and Infection. 2020. 10.1016/j.cmi.2020.05.001 - DOI - PMC - PubMed
    1. Rao M, Rashid FA, Sabri FSAH, et al. Comparing Nasopharyngeal Swab and Early Morning Saliva for the Identification of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2). Clinical Infectious Diseases. 2020. 10.1093/cid/ciaa1156 - DOI - PMC - PubMed